Pretreatment of cadaver donors with methylprednisolone in human renal allografts. 1977

S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine

Fifty cadaveric kidney donors were randomly allocated to two groups. Group 1 received 5 grams of intravenously administered methylprednisolone two to four hours prior to organ harvesting after the pronouncement of brain death. Group 2, which served as the control group, received no pretreatment. Of 100 kidneys harvested, 16 were discarded for various reasons, and 84 were transplanted and were available for evaluation, 40 from the pretreatment group and 44 from the control group. The transplant centers using these kidneys were unaware of the status of the kidney they received, that is, whether it was from a pretreated or a control group. The two groups of kidneys, pretreated and control, did not differ according to the length of warm or cold ischemia time or presence of preformed cytotoxic antibodies. The difference in graft failure between the two groups at three months was insignificant, even when the two groups were compared according to the method of preservation used.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor

Related Publications

S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
June 1980, Transplantation proceedings,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
March 1973, Transplantation proceedings,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
August 1969, The Australian and New Zealand journal of surgery,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
June 1978, Kidney international. Supplement,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
January 1978, Lancet (London, England),
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
September 1998, Journal of the American Society of Nephrology : JASN,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
February 1971, Lancet (London, England),
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
November 1969, Surgery,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
August 1977, Surgery, gynecology & obstetrics,
S N Chatterjee, and P I Terasaki, and S Fine, and B Schulman, and R Smith, and R N Fine
September 1978, Transplantation,
Copied contents to your clipboard!